{
    "organizations": [],
    "uuid": "4e7f1e408f1ff7d824ec584abc920e8cd5004374",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-china-resources-double-crane-pharm/brief-china-resources-double-crane-pharmaceutical-unit-receives-gmp-certificate-idUSL4N1PJ2GY",
    "ord_in_thread": 0,
    "title": "BRIEF-China Resources Double-crane Pharmaceutical unit receives GMP certificate",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 24 (Reuters) - China Resources Double-crane Pharmaceutical Co Ltd\n* Says wholly owned pharmaceutical unit received goods manufacture practice (GMP) certificate from Henan Food and Drug Administration\n* Certificate issued to edaravone manufactured by the unit and the valid period is until Jan. 7, 2023\nSource text in Chinese: goo.gl/2sR7k1\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-24T14:23:00.000+02:00",
    "crawled": "2018-01-25T12:59:06.015+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "china",
        "resource",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "wholly",
        "owned",
        "pharmaceutical",
        "unit",
        "received",
        "good",
        "manufacture",
        "practice",
        "gmp",
        "certificate",
        "henan",
        "food",
        "drug",
        "administration",
        "certificate",
        "issued",
        "edaravone",
        "manufactured",
        "unit",
        "valid",
        "period",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}